| Primary |
| Metastatic Malignant Melanoma |
17.0% |
| Metastatic Renal Cell Carcinoma |
14.9% |
| Renal Cell Carcinoma Stage Unspecified |
13.3% |
| Hiv Infection |
12.4% |
| Malignant Melanoma |
12.0% |
| Renal Cell Carcinoma |
4.6% |
| Gastric Cancer |
3.3% |
| Malignant Melanoma Stage Iv |
3.3% |
| Renal Cancer Metastatic |
3.3% |
| Product Used For Unknown Indication |
2.9% |
| Renal Cancer |
2.1% |
| Chronic Graft Versus Host Disease |
1.7% |
| Metastasis |
1.7% |
| Hepatitis C |
1.2% |
| Metastases To Skin |
1.2% |
| Neuroblastoma |
1.2% |
| Synovial Sarcoma Metastatic |
1.2% |
| Acute Myeloid Leukaemia |
0.8% |
| Breast Cancer Metastatic |
0.8% |
| Colon Cancer |
0.8% |
|
| Vomiting |
14.8% |
| White Blood Cell Count Decreased |
13.6% |
| Thrombocytopenia |
6.2% |
| Rash |
4.9% |
| Renal Failure |
4.9% |
| Renal Failure Acute |
4.9% |
| Tachycardia |
4.9% |
| White Blood Cell Count Increased |
4.9% |
| Metastatic Renal Cell Carcinoma |
3.7% |
| Neuroendocrine Carcinoma Of The Skin |
3.7% |
| Rectal Haemorrhage |
3.7% |
| Retinal Haemorrhage |
3.7% |
| Spinal Cord Compression |
3.7% |
| Systemic Sclerosis |
3.7% |
| Urine Output Decreased |
3.7% |
| Urticaria |
3.7% |
| Weight Decreased |
3.7% |
| Bundle Branch Block Left |
2.5% |
| Cholestasis |
2.5% |
| Convulsion |
2.5% |
|
| Secondary |
| Metastatic Renal Cell Carcinoma |
13.1% |
| Drug Use For Unknown Indication |
9.9% |
| Gastric Cancer |
9.1% |
| Hiv Infection |
9.0% |
| Pancreatic Carcinoma Metastatic |
7.6% |
| Malignant Melanoma |
6.2% |
| Acute Myeloid Leukaemia |
5.3% |
| Metastatic Malignant Melanoma |
5.3% |
| Colon Cancer |
4.2% |
| Colorectal Cancer |
4.2% |
| Neutropenic Sepsis |
3.3% |
| Product Used For Unknown Indication |
3.3% |
| Oesophageal Adenocarcinoma |
3.2% |
| Lymphoma |
3.0% |
| Antibiotic Prophylaxis |
2.7% |
| Renal Cancer |
2.7% |
| Infection |
2.4% |
| Renal Cell Carcinoma Stage Unspecified |
2.0% |
| Angiosarcoma |
1.7% |
| Disseminated Tuberculosis |
1.7% |
|
| Vomiting |
18.7% |
| Pulmonary Oedema |
14.6% |
| Thrombocytopenia |
8.9% |
| Respiratory Rate Increased |
5.7% |
| Tachycardia |
5.7% |
| Renal Failure Acute |
4.9% |
| Venoocclusive Liver Disease |
4.9% |
| Platelet Count Decreased |
4.1% |
| Dehydration |
3.3% |
| Neutrophil Count Decreased |
3.3% |
| Stomatitis |
3.3% |
| Visual Acuity Reduced |
3.3% |
| Acute Myeloid Leukaemia |
2.4% |
| Haemorrhage Intracranial |
2.4% |
| Leukoencephalopathy |
2.4% |
| Pulmonary Embolism |
2.4% |
| Radius Fracture |
2.4% |
| Rectal Haemorrhage |
2.4% |
| Renal Failure |
2.4% |
| Skin Plaque |
2.4% |
|
| Concomitant |
| Metastatic Renal Cell Carcinoma |
8.4% |
| Premedication |
8.2% |
| Stem Cell Transplant |
7.5% |
| Metastases To Bone |
6.4% |
| Hypercholesterolaemia |
5.5% |
| Anxiety |
5.3% |
| Asthma |
5.3% |
| Oedema |
5.3% |
| Gout |
5.0% |
| Hiv Infection |
5.0% |
| Neuropathy |
5.0% |
| Renal Cell Carcinoma Stage Unspecified |
5.0% |
| Thrombosis Prophylaxis |
5.0% |
| Drug Use For Unknown Indication |
4.3% |
| Bone Marrow Conditioning Regimen |
3.7% |
| Klebsiella Infection |
3.4% |
| Hypertension |
3.2% |
| Prophylaxis |
3.0% |
| Cell-mediated Cytotoxicity |
2.7% |
| Immunosuppression |
2.7% |
|
| Wound Infection |
23.0% |
| Thrombocytopenia |
14.9% |
| Nephrogenic Systemic Fibrosis |
6.9% |
| Fatigue |
5.7% |
| Vomiting |
5.7% |
| Vision Blurred |
4.6% |
| Vitreous Floaters |
4.6% |
| Cerebral Haemorrhage |
3.4% |
| Pathogen Resistance |
3.4% |
| Shoulder Pain |
3.4% |
| Tetany |
3.4% |
| Acute Graft Versus Host Disease In Skin |
2.3% |
| Acute Myeloid Leukaemia Recurrent |
2.3% |
| Cytomegalovirus Colitis |
2.3% |
| Haemoptysis |
2.3% |
| Lung Neoplasm Malignant |
2.3% |
| Oesophageal Varices Haemorrhage |
2.3% |
| Pleural Effusion |
2.3% |
| Pulmonary Hypertension |
2.3% |
| Pyrexia |
2.3% |
|
| Interacting |
| Disseminated Tuberculosis |
46.2% |
| Combined Immunodeficiency |
30.8% |
| Pain |
15.4% |
| Glaucoma |
7.7% |
|
| Visual Field Defect |
50.0% |
| Vomiting |
50.0% |
|
